Free Trial

BriaCell Therapeutics (BCTXW) SEC Filings & 10K Form

BriaCell Therapeutics logo
$0.12 -0.01 (-9.57%)
Closing price 04/28/2025 03:53 PM Eastern
Extended Trading
$0.12 +0.00 (+0.84%)
As of 04/28/2025 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent BriaCell Therapeutics SEC Filings

DateFilerForm TypeView
04/24/2025
11:15 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form EFFECT
04/24/2025
4:11 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form S-1MEF
04/24/2025
3:41 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form CERT
04/24/2025
2:46 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-A12B
04/23/2025
3:51 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form S-1/A
04/22/2025
3:26 PM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
Form FWP
02/10/2025
8:02 PM
3i, LP (Filed by)
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
Form SCHEDULE 13G
02/06/2025
3:30 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
4:02 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:05 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
02/03/2025
3:37 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
12/17/2024
3:05 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form DEF 14A
12/13/2024
3:15 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2024
4:27 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
12/12/2024
5:06 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
L5 Capital Inc. (Filed by)
Form SC 13D/A
12/11/2024
4:21 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
12/10/2024
5:06 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
L5 Capital Inc. (Filed by)
Form SC 13D/A
12/05/2024
6:45 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
L5 Capital Inc. (Filed by)
Form SC 13D/A
11/14/2024
11:17 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G/A
11/01/2024
3:05 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
9:12 AM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
10/01/2024
3:02 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
9:22 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
CVI Investments, Inc. (Filed by)
Form SC 13G
09/12/2024
3:25 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
7:50 AM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
7:50 AM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2024
4:00 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2024
3:30 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2024
3:10 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
7:58 AM
BriaCell Therapeutics Corp. (Subject)
BriaCell Therapeutics (Subject)
L5 Capital Inc. (Filed by)
Form SC 13D/A
05/17/2024
3:51 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:10 PM
BriaCell Therapeutics Corp. (Filer)
BriaCell Therapeutics (Filer)
Form 424B5
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCTXW) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners